DVAX
Dynavax Technologies Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$15.50
+0.00%Leverage
- Debt / equity
- 0.53x
- Net debt / equity
- 0.23x
- Debt / assets
- 0.30x
- Debt / EBITDA
- -11.11x
- Net debt / EBITDA
- -4.86x
Liquidity & coverage
- Current ratio
- 7.62x
- Quick ratio
- 6.94x
- Cash ratio
- 6.06x
- Interest coverage
- 1.63x
- EBITDA / interest
- -4.00x
- Working capital
- $707.5M
Cash & dividend
- FCF / debt
- 0.28x
- Cash flow / debt
- 0.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2025